Labviva is a Healthtech company based in Boston. It has raised $55M in total funding. Latest round: Series B.
Labviva funding overview
Labviva is a Healthtech company based in Boston. Labviva has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2023. The round record for Labviva runs through 2023; nothing later has been disclosed. Investors on record include Biospring Partners, Senator Investment Group, B Capital Group, Glasswing Ventures. 4 distinct backers are named across the disclosed rounds.
Labviva at a glance
Total raised
$55M
Latest round
Series B
Latest round date
March 2023
Industry
Healthtech
Headquarters
Boston
Notable investors
Biospring Partners, Senator Investment Group, B Capital Group, Glasswing Ventures
Frequently asked about Labviva funding
How much has Labviva raised?
Labviva has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Labviva?
Biospring Partners, Senator Investment Group, B Capital Group, Glasswing Ventures are named among the investors backing Labviva.
What was the latest Labviva funding round?
The most recent disclosed round is a Series B, announced in March 2023.
Where is Labviva based?
Labviva is based in Boston.
What sector does Labviva operate in?
Labviva is tracked under Healthtech from Boston, with $55M in disclosed funding.
When did Labviva last raise?
The last disclosed Labviva round closed in March 2023 at Series B.
Totals shown for Labviva aggregate every disclosed round on file. To see how that compares, browse the Healthtech companies in Boston and the investors behind them below.
